MENU

  • 第113回日本泌尿器科学会総会

Program

icon

Keynote Lecture

April 26 Sun. 11:45-12:00 / Room1(1F/RoomC-1)

Focal therapy as a fiedld: The future of FT for PCa

Speaker
Andre AbreuUniversity of Southern California, USA
Andre Abreu

25th April.

icon

Session 1

April 25 Sat. 8:10-9:25 / Room1(1F/RoomC-1)

Imaging

Moderator
Eduard BacoOslo University Hospital, Norway
Tsuyoshi IwataKyoto Min-iren Chuo Hospital, Japan
S1-1Biparametric MRI should be a new standard of care for prostate cancer diagnosis: results from the PRIME trial
Speaker
Veeru KasivisvanathanUniversity College London and University of Vienna, United Kingdom
S1-2MRI interpretation for selection and follow up after Focal Therapy for PCa
Speaker
Andrei S. PuryskoCleveland Clinic, USA
S1-3PSMA-PET for patient selection and follow up for Focal Therapy for Prostate Cancer
Speaker
Andrei S. PuryskoCleveland Clinic, USA
S1-4Multiparametric Ultrasound for selection, intra-operative evaluation and follow up after focal therapy for Pca
Speaker
Osamu UkimuraKyoto Prefectrual University of Medicine, Japan
S1-5Salvage options for radiorecurrent localized prostate cancer
Speaker
Tarik BenidirUniversity of Florida, USA
icon

Session 2

April 25 Sat. 8:30-9:45 / Room2(1F/RoomC-2)

Patient Selection

Moderator
Ardeshir RastinehadNorthwell Health, USA
Sunao ShojiTokai University School of Medicine, Japan
S2-1Patient selection and the Ideal Candidate for FT for Pca
Speaker
Andre AbreuUniversity of Southern California, USA
S2-2Expanding indications of Focal therapy: Rationale for Treating High Risk Pca
Speaker
Ardeshir RastinehadNorthwell Health, USA
S2-3Do genomic biomarkers have a role in patient selection for Focal Therapy?
Speaker
Bruno NaharUniversity of Miami, USA
S2-4Contemporary Patient Selection for Focal Therapy in Localized Prostate Cancer: A Risk-Adapted, Biologically Informed Framework
Speaker
Ardalan AhmadUniversity of Manitoba, Canada
S2-5Focal or radical therapy: Lesion-based Molecular Evaluation in Prostate Cancer (FLAME-PC)
Speaker
Kae Jack TaySingapore General Hospital, Singapore
icon

Session 3

April 25 Sat. 10:30-11:00 / Room2(1F/RoomC-2)

Artificial Intelligence

Moderator
Andre AbreuUniversity of Southern California, USA
Masatomo KanekoKyoto Prefectural University of Medicine, Japan
S3-1AI and MRI implications for patient selection, intra-operative guidance and follow up after FT for PCa
Speaker
Masatomo KanekoKyoto Prefectural University of Medicine, Japan
S3-2Targeted Microwaves Ablation TMA, a new Focal Therapy for localized Prostate Cancer: from in vivo experimentation to clinical application.
Speaker
Alexandre PeltierJules Bordet Institute, Belgium
icon

Session 4

April 25 Sat. 13:15-15:00 / Room1(1F/RoomC-1)

Focal Therapy Outcomes

Moderator
Peter Ka-Fung ChiuThe Chinese University of Hong Kong, Hong Kong
Kae Jack TaySingapore General Hospital, Singapore
S4-1Outcomes of prostate cancer focal therapy in Asia a multi-institutional and multi-modality study
Speaker
Peter Ka-Fung ChiuThe Chinese University of Hong Kong, Hong Kong
S4-2Prospective Observational Asian Multicenter Focal therapy study (ProAMFocal)
Speaker
Kae Jack TaySingapore General Hospital, Singapore
S4-3Follow up, Regular convalescence, complications and regrets after FT for Pca
Speaker
James WysockNYU School of Medicine, USA
S4-4Biopsy Gleason Pattern 4 Burden Improves Prediction of Adverse Pathology and 3-Year Biochemical Recurrence After Radical Prostatectomy
Speaker
Kara WattsMontefiore Medical Center, USA
S4-5Clinical evidence Supporting FT: Impacts on Guidelines
Speaker
Munehiro OhasiKyoto Tanabe Central Hospital, Japan
S4-6MRI-based management of FT for PCa
Speaker
Sunao ShojiTokai University School of Medicine, Japan
S4-7Back to the future, subtotal ablation should be the standard: balancing QoL vs optimal PCa control
Speaker
Inderbir GillUniversity of Southern California, USA
icon

Session 5

April 25 Sat. 14:15-16:30 / Room2(1F/RoomC-2)

Improving Focal Therapy Outcomes

Moderator
Thomas PolascikDuke Cancer Institute, USA
Sunao ShojiTokai University School of Medicine, Japan
S5-1Focal HIFU for Prostate Cancer: Lesion Volume Correlated to Biopsy Result Post Treatment
Speaker
Cary N RobertsonDuke University Medical Center, USA
S5-2Come with less, expect more? Baseline sexual function as a critical lens for interpreting whole-gland vs partial-gland cryoablation outcomes: insights from 20+ years of experience
Speaker
Thomas PolascikDuke Cancer Institute, USA
S5-3Contrast Enhanced Ultrasound for Real Time Post Ablative Margin Assessment
Speaker
Tarik Benidir University of Florida, USA
S5-4The Apex: how to handle apical lesions with Focal Ablation; Technical and Procedural considerations.  Anatomy Matters: Location Dictates Energy Selection for Partial Prostate Gland Ablation.
Speaker
Jonathan Samuel FainbergMemorial Sloan Kettering Cancer Center, USA
S5-5Prostate Compression for HIFU
Speaker
Sunao ShojiTokai University School of Medicine, Japan
S5-6Focal Therapy and (neo)adjuvant therapy
Speaker
Fernando J. BiancoNOVA SouthEastern University, USA
icon

Session 6

April 25 Sat. 15:15-16:00 / Room1(1F/RoomC-1)

Guidance

Moderator
Atsuko FujiharaKyoto Prefectural University of Medicine, Japan
Toshitaka ShinOita University Faculty of Medicine, Japan
S6-13D navigation for focal therapy for Pca
Speaker
Atsuko FujiharaKyoto Prefectural University of Medicine, Japan
S6-2Telesurgery in Focal Therapy
Speaker
Ruben Olivares GribbellCleveland Clinic, USA
S6-3Robotic MRI/US fusion Guided Irreversible Electroporation in Intermediate Risk Prostate Cancer utilizing the Biobot Mona Lisa 2.0 Platform
Speaker
Srinivas VourgantiRush University Medical Center, USA

26th April.

icon

Session 7

April 26 Sun. 7:30-9:30 / Room1(1F/RoomC-1)

Clinical Trials

Moderator
Inderbir GillUniversity of Southern California, USA
Atsuko FujiharaKyoto Prefectural University of Medicine, Japan
S7-1Critical apraisai of current clinical trials in FT for Pca
Speaker
Soroush Rais-BahramiWake Forest University School of Medicine, USA
S7-2HIFI-HIFU vs RALP
Speaker
Sébastien CrouzetUniversity Claude Bernard LYON 1, France
S7-3Water Ⅳ- Aquablation vs RALP
Speaker
Inderbir GillUniversity of Southern California, USA
S7-4The Captain Trial: TULSA vs RP
Speaker
Laurence KlotzUniversity of Toronto, Canada
S7-5Latest Update on the Oncological Results of the RCT Comparing Focal Ablation versus Robotic Prostatectomy in Patients with Unilateral Clinically Significant Prostate Cance
Speaker
Eduard BacoOslo University Hospital, Norway
S7-6Cryoablation in metastatic prostate cancer: a scoping review
Speaker
Thomas PolascikDuke Cancer Institute, USA
S7-7IRE(PRESERVE)- Singke Arm IRE
Speaker
Derek LomasMayo Clinic, USA
S7-8ProFocal laser- Single Arm Laser
Speaker
Isaac ThangasamyUniversity of Sydney, Australia
S7-9Targeted Microwave Ablation of Localized Prostate Cancer (VIOLETTE) : A Prospective, Multicentre Study
Speaker
Julien AnractParis Cite University, France
icon

Session 8

April 26 Sun. 8:45-10:00 / Room2(1F/RoomC-2)

Tumor Board1

Moderator
Sébastien CrouzetUniversity Claude Bernard LYON 1, France
Mihir DesaiUniversity of Southern California, USA
S8-1HIFU
Speaker
Sunao ShojiTokai University School of Medicine, Japan
S8-2HIFU
Speaker
Sébastien CrouzetUniversity Claude Bernard LYON 1, France
S8-3IRE
Speaker
Jonathan Samuel FainbergMemorial Sloan Kettering Cancer Center, USA
S8-4CRYO
Speaker
Osamu UkimuraKyoto Prefectural University of Medicine, Japan
S8-5Aquablation
Speaker
Mihir DesaiUniversity of Southern California, USA
icon

Session 9

April 26 Sun. 10:15-11:30 / Room1(1F/RoomC-1)

Tumor Board2

Moderator
Yoh MatsuokaSaitama Cancer Center, Japan
Eduard BacoOslo University Hospital, Norway
S9-1 Clinical Outcomes of Focal Low-Dose-Rate Brachytherapy for Localized Prostate Cancer
Speaker
Yoh MatsuokaSaitama Cancer Center, Japan
S9-2TBD
Speaker
Issac ThangasamyUniversity of Sydney, Australia
S9-3TULSA
Speaker
Eduard BacoOslo University Hospital, Fench and Norway
S9-4Targeted Microwave Ablations: a global approach of focal therapy for localized prostate cancer
Speaker
Julien AnractParis Cite University, France
S9-5Partial Prostatectmomy
Speaker
Ruben Olivaras GribbellCleveland Clinic, USA
  • 第113回日本泌尿器科学会総会